GLP-1 injections are generally considered safe for long-term use when administered under medical supervision
therefore, ethical approval and informed consent were not required
Market Inclusions This report covers global and regional market sizes for GLP1 receptor agonists over a defined forecast period, including drug classes (injectables, oral formulations), major therapeutic indications (type 2 diabetes, obesity), and distribution channels (hospitals, retail pharmacies, specialty clinics)
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists
This shift toward chronic therapy occurred because the benefits extend well beyond glycemic control
Drawing on the latest research, Dr